Tim-3, a molecule involved in immune regulation, hinders plaque removal in Alzheimer’s disease. Blocking it in microglia improved brain health in mice, making it a potential treatment target. Tim-3 is ...

New research reveals that the immune checkpoint molecule Tim-3 plays a critical role in how microglia, the brain’s immune cells, respond to Alzheimer’s disease.

Researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master regulator that hinders the effectiveness of immunotherapy -- opening a new path for lung ...

Researchers are exploring strategies to alter the gut microbiome to improve patients’ responses to immunotherapy. New ...

The research team, led by Professor Tu Wenwei (second right) and Professor Wang Weiping (second left), has made a ...

KAIST researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master ...

In mouse models, the approach has been proven effective in activating immune cells to target and destroy cancer cells, inhibiting tumour growth. Combining this method with existing immunotherapy has ...

When your body senses something is wrong—whether it's a damaged cell or a growing tumor—it can react in many ways. One of the ...

About 65% of melanoma patients do not respond to immunotherapy. New work by the team of Prof. Max Mazzone (VIB-KU Leuven ...

Scientists found that dormant viral genes can be reactivated in kidney cancer, prompting an immune response, offering new ...

Modern cancer treatments have evolved beyond traditional chemotherapy to include targeted approaches such as immunotherapy, ...